Subset of anaplastic glioma patients benefit from adjuvant chemo

ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?

Advanced RET-rearranged NSCLC

Global drug pricing: How cost-effective is bevacizumab?

CPX-351 improves outcomes for refractory AML

First in-human trials of rovalpituzumab for SCLC

Surgery in stage 4 breast cancer increased survival

Trial shows exercise beneficial for patients undergoing chemotherapy

Elderly patients with glioblastoma live longer with chemoradiation using temozolomide

Intraperitoneal chemotherapy slows ovarian cancer progression

Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer